Bioorg Chem 106:104492 Pan Q, Lin S, Li Y, Liu L, Li X, Gao X, Yan J, Gu B, Chen X, Li W, Tang X, Chen C, Guo L (2021) A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
Policymakers and clinicians should continue to closely monitor trade-offs between pharmacologic and surgical management of obesity to ensure optimal access to effective obesity treatment, the researchers concluded.
IR injury induced by heart transplantation is a clinically significant form of sterile inflammation
Mexican regulators have signaled more aggressive action against pharmacies that sell prescription medications without proper documentation
Cannot redeclare control with same name "grid_6_product_image"
Optimising GLP-1/GIP targeting for individual patients We are currently working to clarify how exactly each receptor works by investigating how they move across the cells of the pancreas, the signals they send, and the partners they interact with
.jpg)
